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The blood-group isoantigens are macromolecules
localized to the plasma membranes of certain epi-
thelial tissues. 211-15 These substances are not
detectable on the epithelium once it has under-
gone malignant transformation.Z9,13 Results of
this investigation have demonstrated that the loss
of detectability of the blood-group isoantigens
does not appear to be related to a "masking"
effect by an increase in surface sialic acid. Using
fluorescein-labeled lectins specific for sugar sub-
units which are components of the blood-group
oligosaccharide chain, it was found that the malig-
nant cells and cells of the parabasal layer of
normal oral epithelium had high levels of N-acetyl-
D-glucosamine (GlcNAC), the subterminal sugar
residue of the blood-group chain. The basal cells of
normal epithelium and a minority of the malignant
cells demonstrated levels of D-galactose-N-acetyl-
D-galactosamine, which are the most proximal
blood-group sugar subunits, as well as subunits of
other membrane antigens.
Our results indicate that malignant cells seem to
be capable of synthesizing the blood-group oligo-
saccharide chains to the same level as the normal
cells of the parabasal layer of stratified squamous
epithelium. This level is just subjacent to the
terminal D-galactose residue of the blood-group
precursor chain. Increased or decreased differentia-
tion characteristics of squamous cell carcinomas
did not alter the level of blood-group synthesis.
However, there may be a correlation between the
level of synthesis of these antigens and the ability
of the cells to demonstrate motility and to
proliferate.
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Introduction.
Previous studiesl4 have demonstrated that
malignant oral squamous epithelial cells are
non-reactive to antisera directed against the
blood-group isoantigens. Normal epithelial
cells above the parabasal layer of the strati-
Received for publication November 21, 1979
Accepted for publication March 26, 1980
*Current address: 4009 Hayfield Way,
Prospect, KY 40059
2014
fied squamous epithelium have the blood-
group substances located on their plasma
membranes and therefore react with anti-
bodies directed against these isoantigens.
Non-malignant lesions previously tested in
our lab, such as epithelial hyperplasias and
papillomas, also demonstrate plasma mem-
brane blood-group isoantigens.1 Previous
investigators have reported that epithelium
extending across oral wound margins fails to
demonstrate reactivity for the blood-group
substances.5'6 Therefore, it appears that cells
which fail to demonstrate blood-group
reactivity are cells which actively proliferate
and demonstrate motility. These cells are
the basal and parabasal cells of normal
epithelium, normal cells proliferating across
a wound margin, and malignant epithelial
cells.
The present study sought to investigate
the failure to demonstrate the "complete"
blood-group oligosaccharide antigens on
some normal cell populations, as well as on
the malignant cell surfaces. This loss of
antigen detectability was considered to be
caused by one of two mechanisms. The first
of these dealt with a possible increase in cell
surface sialic acid which could "mask" the
blood-group specific sugars.7 The second
was that malignant cells and normal cells of
the basal and parabasal cell layers may not
synthesize the "complete" blood-group
oligosaccharide chains. We hoped to deter-
mine any similarities between the malignant
cells and the cells of the basal and parabasal
layers of normal oral stratified squamous
epithelium.
Materials and methods.
Specimens of fresh oral malignant and
non-malignant tissue were obtained from the
Otolaryngology Department at the Univer-
sity of Michigan Hospital, as well as from the
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Department of Oral Surgery, School of
Dentistry. Consent of the patient was ob-
tained for the use of the specimen after
an explanation of its use was provided.
The blood-type was recorded in almost
all cases. Paraffin-embedded specimens were
obtained from the Department of Oral
Pathology, School of Dentistry, University
of Michigan.
The fresh tissue specimens were initially
placed in phosphate-buffered saline (PBS) at
10C after surgical removal. Two methods
for examining this fresh tissue were utilized.
One group of specimens was removed from
the PBS, mounted on a metal cryostat
freezing stage with an embedding com-
pound,* and frozen quickly in liquid
nitrogen. Once frozen, the tissue was sec-
tioned on a cryostat at 4 pm, transferred to
precleaned glass slides, and allowed to air
dry for ten min. The second technique for
utilizing the fresh surgical specimens was to
fix them in 2% glutaraldehyde in cacodylate
buffer, while stirring for 15 min at 40C.
The tissue was then rinsed in PBS, frozen,
and sectioned as above. Hematoxylin- and
eosin-stained sections were made of each
sample in order to determine the exact
content of the specimen. Paraffin-embedded
tissue specimens were sectioned at 4 pm and
deparaffinized in a xylene rinse for 30 min,
followed by 100% alcohol and 70% alcohol
for 15 min each. These were then rehydrated
in PBS.
Blood-group reactivity. -In order to test
for the "complete" blood-group glyco-
proteins, the tissue sections were first
rinsed with PBS for 15 min, patted dry with
absorbent paper, and then incubated in a
drop of blood-group antisera in a humidity
chamber for one h at 20°C. This antiserum
consisted of human anti-A and anti-Bt
at a dilution of 1:16. The specificity of the
antiserum to be used was determined by the
patient's blood type or by trial and error,
until positive results were obtained on areas
of normal epithelium or on the endothelial
cells of capillaries.1
Following the antisera, the slides were
rinsed in PBS for 30 min at 20°C to remove
any non-binding antiserum from the tissue
section. The slides were patted dry and
covered with a drop of fluorescein isothio-
cyanate-labeled (FITC) rabbit anti-human
immunoglobulin.t This fluorescent anti-
immunoglobulin was reacted with the tissue-
bound antisera for one h. Non-binding
rabbit anti-immunoglobulin was rinsed off in
PBS for 30 min, and the slides were counter-
stained with a 40X dilution of eriochrome
black stain for 15 sec. A "thin-O" coverslip
was then sealed over the tissue section with
clear fingernail polish, and the slide was
viewed on a Leitz fluorescent microscope.
Blood-group 0 antigen was tested with
the fluorescein-labeled lectin Lotus tetra-
gonobolus. ¶ This lectin, diluted 1:80,
was applied to the tissue sections in a
humidity chamber for one h. Since the lectin
itself was fluorescent, a sandwich technique
needed for the human antiserum was not
used. The slides were counterstained with
eriochrome black and coverslipped, as
described above.
Sialic acid removal. - Tissue sections
were reacted with Vibrio cholerae neur-
aminidase (VCN, 500 U/ml)§ for one h at
37°C, pH 5.5, following initial rinsing in
Medium 199. The neuraminidase was diluted
to concentrations of 25 U/ml, 100 U/ml,
and 250 U/ml with Medium 199, pH 5.5.
The tissue sections were then rinsed three
times in PBS to remove the enzyme. Fol-
lowing removal of the VCN, the tissue sec-
tions were tested for the "complete" blood-
group substances (described previously),
as well as for the blood-group subunits
as described below. Periodic acid-Schiff
staining was also performed on sections
treated with VCN and on controls which
were not reacted with the enzyme. This
histochemical technique is useful in
determining the presence or absence of sialic
acid on tissue sections.18
Lectins. -Several plant lectins which are
specific for certain sugars on the cell mem-
brane surface and labeled with FITC were
* Bio-Rad Laboratories, Richmond, CA
1 E-Y Laboratories, San Mateo, CA
§GIBCO, Grand Island, NY
*Lipshaw M-1 Embedding Matrix, Lipshaw
Manufacturing Co., Detroit, MI
tHyland, Costa Mesa, CA
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purchased from E-Y Laboratories. These
lectins were titered 1:80 in order to obtain
acceptable fluorescence.
The sialic acid content of both normal
and malignant tissue specimens was inves-
tigated. The lectin Limulin polyhemus
agglutinin, with specific cross-reactivity for
the sugar N-acetylneuraminic acid, was used
to study sialic acid distribution. Also used
were Dolichos biflorus agglutinin, specific
for N-acetyl-D-galactosamine (blood-group A
substance), and Arachis hypogae agglutinin
(Peanut agglutinin), specific for the sugars
D-galactose-g-( 1-3)-N-acetyl-D-galactosamine
(a blood-group subunit). Triticum vulgaris
agglutinin (wheat germ agglutinin), specific
for N-acetyl-D-glucosamine, and Banderirea
simplicifolia LI, specific for only terminally
positioned N-acetyl-D-glucosamine,l7 were
tested as well.
Controls for these lectins were conducted
consisting of immunocompetition between
the lectin and its specific sugar prior to the
application to the tissue section. This
resulted in a complete absence of tissue
fluorescence. As negative controls, the lectin
was mixed with an incorrect sugar which
caused no reduction in fluorescence. Anti-
body controls were built into many of the
sections, due to the presence of areas of non-
malignant epithelium or endothelial cells of
blood vessels. The authors have previously
found that these cells demonstrate normal
blood-group reactivity.1
Results.
Previous studiesl'2 have shown that
"complete" blood-group oligosaccharide
chains (A, B, 0) are present and reactive in
the strata spinosum and corneum layers
(middle and upper layers) of normal oral
squamous epithelium (Fig. 1). These findings
are in agreement with the results of our
current investigation as can be seen in the
Table. Fluorescein-labeled immunoglobulins
against the blood-groups A and B were
found to be reactive to cells above the para-
basal layer of normal epithelium (Fig. 2).
Malignant epithelium showed no reactivity
to these "complete" blood-group antibodies.
Limulin polyhemus agglutinin, specific for
sialic acid, failed to demonstrate reactivity
on the normal or malignant epithelial cells
(Table), and treatment with neuraminidase






Fig. 1 Immunofluorescent blood-group
reactivity of normal epithelium. Shaded area
represents reactive cell layers.
Fig. 2 Fluorescein-labeled anti-A reactivity
of the normal stratum corneum and keratin epithe-
ial layers. 200x
of the PAS histochemical analysis before and
after neuraminidase digestion of the tissue
sections also failed to demonstrate the
presence of sialic acid on the normal or
malignant epithelial cell plasma membranes.
Lotus tetragonobolus (Lotus A), used to
test for L-fucose or the H substance, demon-
strated a weak and randomly isolated
reactivity on the plasma membranes of
normal stratum spinosum cells in non-type
O individuals. No reactivity to L-fucose was
detected on the malignant cells. N-acetyl-
D-glucosamine (GLcNAC) was found to be
the most reactive sugar on the plasma
membranes of the parabasal and lower
spinous cell layers of normal epithelium
using Triticum vulgaris agglutinin (wheat
germ agglutinin, WGA) and the lectin
Bandeirea simplicifolia II, which is specific
for only the terminally located N-acetyl-
glucosamine (Figs. 3, 4, and Table).17
Malignant epithelial cells demonstrate high
levels of N-acetyl-D-glucosamine on their
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results of cellular membrane reactivity were
obtained with both of the above lectins. D-
galactose-N-acetyl-D-galactosamine reactivity
was limited solely to the basal cell layer of
normal epithelium (Figs. 6, 7, and Table)
and was only mildly present on the cell
membranes of malignant epithelial cells
as determined by the fluorescein-labeled
lectin Arachis hypogae agglutinin (Peanut
agglutinim, PNA) (Table).
Fig. 8 illustrates a schematic of the M
oligosaccharide sequence specific for the
blood-group B.16 The group-specific sugar
for the B blood-group is the final galactose (a)
ANT I -GLCNAC (WGA)
- KERATIN LAYER
SPINOUS LAYER
- PARABASAL LAYER~~~~BASAL LAYER
Fig. 3 Immunofluorescent reactivity of Fig. 4 N-acetyl-D-glucosamine reactivity o:
parabasal cell layers to anti-N-acetyl-D-glucosamine the parabasal and lower spinous cell layers ol
(GlcNAC). Shaded area represents reactive cell normal oral epithelium. FITC-labeled Triticun
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level of blood-group differentiation cor-
relates with the parabasal cell layers of
normal epithelium. Another similarity exists
between these cell types in that both can
actively divide and both have the capacity of
cell motility.6 We tested for the final sugar
residues of Galactose-N-acetyl-D-galactos-
amine (Gal-GALNAC) (Fig. 8) using the
lectin Arachis hypogae (Peanut agglutinin)
on the malignant cells. These were found to
be present, but in smaller amounts than that
of the N-acetyl-D-glucosamine (GlcNAC) sub-
terminal residue. Similar results have been
obtained by others.6 This may indicate that
malignant cells are able to synthesize the
blood-group oligosaccharides to the level of
N-acetyl-D-glucosamine (GlcNAC) but no
further. It was found from our investigation
that the degree of histologic "differentia-
tion" of the squamous cell carcinoma cells
did not influence the level at which the
blood-group oligosaccharides were termin-
ated. Even in neoplasms which formed
large amounts of keratin, indicating a high
degree of cellular differentiation similar to
the cells of the cornifying layers of the
normal epithelium, the blood-group reactiv-
ity was found to be terminated at the level
of N-acetyl-D-glucosamine.
From our results it appeared that the
incomplete synthesis of the blood-group
substances on the surface of epithelial
cells may be related to the ability of the cell
to move through adjacent tissues rather
than to divide mitotically. This idea has
also been proposed by Dabelsteen.6 Several
examples illustrate this hypothesis. The basal
and parabasal cells of normal stratified
squamous epithelium are cells which active-
ly migrate toward the surface, while the
remaining superficial layers are probably
pushed passively toward the surface by the
expanding bottom layers. Our study has
shown that incomplete blood-group sub-
stances may be present in these lower cell
layers. In epithelium adjacent to wound
margins, Dabelsteen and Mackenzie have
shown that the complete blood-group
substances are not detectable.5'6 These cells
are actively dividing in order to heal the
wound, but are also migrating across and
through the adjacent connective tissue in
order to form a new surface epithelium.
Once the opposing edges of the migrating
epithelium contact each other, it has been
found that the blood-group substances
appear on the cell membranes.5'6
Several benign oral epithelial neoplasms
such as the papilloma were tested pre-
viously1 and found to demonstrate com-
plete blood-group antigens. These benign
neoplasms often exhibit a rapid mitotic
rate; however, this does not appear to affect
the cell surface antigenicity. Benign neo-
plasms, unlike their malignant counter-
parts, do not actively migrate through
adjacent tissues. Therefore, it is possible
that they do not have to demonstrate
altered cell surface antigens, such as the
blood-group antigens.
The findings of our study suggest that
cell migration is related to the degree of
development of the plasma membrane.
Other cell functions such as keratin produc-
tion do not appear to be related to the
degree of membrane antigenicity, since
many of the malignant neoplasms tested in
our current study showed keratin produc-
tion, but not complete blood-group oligo-
saccharides.
Sialic acid did not appear to be involved
in a "masking" of the blood-group sub-
stances, since the antigens could not be
detected following neuraminidase enzyme
treatment. No sialic acid was detected on the
surface of malignant cells using FITC lectins
or histochemical staining techniques.
Therefore, it appears that malignant oral
squamous epithelial cells may terminate
synthesis of the blood-group oligosaccharide
chains at a particular level of complete-
ness, regardless of the degree of differentia-
tion of the neoplasms. Further investigations
regarding the mechanism involved in this
specific termination are being conducted
in our lab. It is possible that the incomplete
blood-group phenotype is secondary to
abnormally produced glycosyltransferase en-
zymes responsible for the construction of
the sugar chains.10
Conclusions.
1. The blood-group oligosaccharide chains
normally reactive on the spinous cell layers
of normal stratified squamous epithelium
are not detectable on malignant epithelial
cells.
2. Normal basal and parabasal cells of
stratified squamous epithelium do not
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demonstrate "complete" blood-group anti-
gens on their cell membranes.
3. The blood-group substances on the
above-mentioned cells do not appear to be
"masked" by a surface coating of sialic acid.
4. The synthesis of the blood-group
oligosaccharide chains is incomplete, pos-
sibly terminated at the level of the sub-
terminal N-acetyl-D-glucosamine sugar
residue on the parabasal cells of normal
stratified squamous epithelium and on
malignant epithelial cells.
5. The synthesis of the blood-group
oligosaccharide chains may be incomplete
at the level of the proximal N-acetyl-D-
galactosamine on the basal cells of normal
epithelium.
6. The degree of "differentiation" of the
malignant cells did not alter the level of
termination of the blood-group oligosac-
charide chain.
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